GLP-1 medications have reshaped how modern medicine approaches weight and metabolic health. Here is a clear, provider-informed look at what they do and why they work.
GLP-1 (glucagon-like peptide-1) is a hormone your body releases after you eat. It helps regulate appetite, slows how quickly your stomach empties, and supports healthy blood-sugar levels. Medications like Semaglutide and Tirzepatide are built to mimic and extend that natural signal.
By reducing appetite and the constant mental noise around food, GLP-1 therapy makes a calorie deficit far easier to hold. Most people lose weight steadily over months instead of crashing and rebounding.
Many patients say the biggest change is mental. Cravings and preoccupation with food quiet down, so healthier choices stop feeling like a daily fight.
GLP-1s were first studied in metabolic health. By supporting insulin response and steadier blood sugar, they work on weight at a metabolic level, not just on the scale.
Food stays in your stomach longer, so you feel full sooner and stay full longer between meals.
Semaglutide acts on the GLP-1 receptor. Tirzepatide is a dual agonist that acts on both the GLP-1 and GIP receptors, which can mean stronger results for the right candidate. Which one fits you is a clinical decision your provider makes after reviewing your intake.
GLP-1 therapy works best when a provider titrates your dose gradually and watches how you respond. Compounded GLP-1s are prepared by US-licensed pharmacies and are not FDA-approved. At FreedomMD, every protocol is provider-directed and requires a prescription, and your member price stays locked as your dose climbs.